| Course | DDBA 8531 Seminar in B2B Marketing |
|---|---|
| Week | Week 2 |
| Paper type | Buying center map |
| Length | About 820 words, 5 pages |
| Format | APA 7 student paper |
| School | Walden University |
| Program | Doctor of Business Administration (DBA) |
| Updated | October 2026 |
Free sample paper for DDBA 8531 Week 2
Seven Participants, Three Vetoes and One Administrator Nobody Planned For: A Buying Center Map of a Health System's Infusion Pump Replacement, With the Evidence Behind Each Placement
Student Name
Walden University
DDBA 8531: Seminar in B2B Marketing
Instructor Name
Month Day, Year
Seven Participants, Three Vetoes and One Administrator Nobody Planned For: A Buying Center Map of a Health System's Infusion Pump Replacement, With the Evidence Behind Each Placement
The Purchase
A composite three-hospital health system in western Pennsylvania, with 940 licensed beds, replaced its large-volume infusion pumps in 2025. The purchase covered about 1,350 pump channels, software licenses and a seven-year service agreement, at a total of about $4.2 million. Two vendors reached the final evaluation. This paper maps the system's buying center: who took part, what role each played, what test each applied, who could stop the purchase and what evidence supports each placement.
The Map
[after]
Evidence came from the value analysis committee's minutes for six meetings, the committee charter, the system's vendor access policy, a published job posting for the informatics lead's position and interviews with the biomedical engineering manager and a nurse educator who sat on the panel.
Table 1
Buying Center for the Infusion Pump Replacement
| Participant | Role | Test applied | Veto | Evidence | |
|---|---|---|---|---|
| Bedside nurses (12 on the evaluation panel) | User, influencer | Programming steps, alarm behavior, weight and pole mounting | Practical | Trial scorecards, panel roster | |
| Biomedical engineering manager | Influencer, gatekeeper | Service terms, parts availability, preventive maintenance hours | Practical | Committee minutes, interview | |
| Clinical informatics lead | Influencer | Whether pumps send infusion data to the medication record | Formal | Job posting, committee minutes | |
| Supply chain director | Buyer | Price, contract terms, group purchasing pricing | None | Contract file | |
| Value analysis committee | Decider | Clinical evidence, total cost, standardization | Formal | Committee charter, minutes | |
| Chief financial officer | Decider | Capital budget fit, payment schedule | Formal | Capital plan | |
| Department administrator, pharmacy | Gatekeeper | Vendor access to staff and drug library data | Practical | Vendor policy, interview | |
Where Roles Overlap
Webster and Wind (1972) described roles as functions in the buying process, not as job titles, so one person can hold several. The biomedical engineering manager was both an influencer, since service terms carried weight in the scoring, and a gatekeeper, since his department controlled which vendor representatives could see the existing pump fleet and its repair history. Nurses were users and influencers at once: their trial scorecards counted for 30 percent of the value analysis committee's weighting.
Where Power Differs From Title
Formal authority sat with the value analysis committee and the chief financial officer. But practical vetoes sat elsewhere. The clinical informatics lead's test, whether pumps could exchange data with the medication record, eliminated one vendor's older model early, before the committee scored it. That was a formal veto written into the committee charter, which requires informatics approval for any device that connects to the network. The pharmacy administrator held a practical veto of a different kind: the vendor policy gave pharmacy control over access to the drug library, the list of medications and dose limits programmed into each pump, and one vendor's representatives were refused access for three weeks because they had not completed the required credentialing. Johnston and Bonoma (1981) found that buying centers for important, complex purchases involve more people across more departments and more levels of the organization, and this purchase fits that finding.
The Participant the Seller Met Least
Sellers tend to spend their time with the people whose job is to receive them, usually purchasing staff, while participants elsewhere in the organization go unaddressed. Bonoma and Johnston (1978) argued that industrial buying is a social process among people with different goals and influence, which implies that a seller who meets only one of them sees only part of the decision. The vendor that lost met the supply chain director eleven times and the pharmacy administrator once, according to the system's visitor logs. The winning vendor met pharmacy four times. Nobody planned for the pharmacy administrator to matter, but the drug library is where pump safety is configured, and the administrator controlled the time vendors needed to build it.
Who Talks to Whom
[after]
The biomedical engineering manager was mentioned most often in the minutes, which reflects his position as a link between nursing, informatics and the vendors.
Figure 1
Communication Links Recorded in Committee Minutes
What the Map Means for a Seller
A seller reading this map would plan its calls differently from one reading the organization chart. The chart shows the supply chain director and the chief financial officer at the center; the map shows that nurses' scorecards, the informatics charter and pharmacy's control of drug library access decided which vendor could compete at all. Contact with each veto holder should be planned for the stage at which that person's test is applied, informatics before the committee scores, pharmacy as soon as credentialing opens.
Limits of the Map
The map rests on documents and two interviews. Minutes record what was said in meetings, not conversations outside them, and the interviews may overstate their subjects' importance. Lilien and Wong (1984) found that buying center involvement varies across stages of the purchase, and this map summarizes the whole process rather than stage by stage.
References
Bonoma, T. V., & Johnston, W. J. (1978). The social psychology of industrial buying and selling. Industrial Marketing Management, 7(4), 213-224. https://doi.org/10.1016/0019-8501(78)90038-x
Johnston, W. J., & Bonoma, T. V. (1981). The buying center: Structure and interaction patterns. Journal of Marketing, 45(3), 143-156. https://doi.org/10.1177/002224298104500312
Lilien, G. L., & Wong, M. A. (1984). An exploratory investigation of the structure of the buying center in the metalworking industry. Journal of Marketing Research, 21(1), 1-11. https://doi.org/10.1177/002224378402100101
Webster, F. E., Jr., & Wind, Y. (1972). A general model for understanding organizational buying behavior. Journal of Marketing, 36(2), 12-19. https://doi.org/10.1177/002224297203600204
Reading the DDBA 8531 Week 2 instructions
Week 2 asks for a map of one organization's buying center for a single purchase. Choose a purchase large enough to involve several departments. Lay out one table line per participating function, and columns for role, the test applied, veto power and the evidence that places the person there, such as minutes, charters, job postings or interviews. Write commentary on three questions: where roles overlap, where practical power differs from formal title and which participant the seller met least often. A simple diagram of communication links helps. Close by stating what the map cannot show, given the documents you used.
How the DDBA 8531 Week 2 example is put together
The sample table has seven rows, from twelve bedside nurses on the evaluation panel to the pharmacy administrator. Tests are specific: programming steps and alarm behavior for nurses, service terms for biomedical engineering, data exchange with the medication record for informatics. The overlap section shows biomedical engineering as both influencer and gatekeeper and nurses' scorecards carrying 30 percent of the weighting. The power section explains how the informatics charter eliminated one vendor's older model early and how pharmacy held off a vendor for three weeks over credentialing. Visitor logs show the losing vendor met supply chain eleven times and pharmacy once, and a chart counts mentions in committee minutes. A limits section notes that minutes miss conversations outside meetings and that interviewees may overstate their own importance, and a closing passage explains how a seller would schedule contact with each veto holder at the stage that person's test applies.
Where the marks sit in the DDBA 8531 Week 2 rubric
Evidence behind each placement carries the most weight; a neat table without sources is a guess. Faculty then read the tests, rewarding those stated as questions a real participant asked over labels such as quality or cost. The veto column earns credit when it separates formal authority from practical power and explains where they diverge. Commentary should interpret rather than repeat the table. The seller-contact analysis shows the map's use to a marketer. Common deductions include omitting a gatekeeper who controls access or scheduling, assigning roles by job title alone and ignoring how membership changed as the purchase moved forward.
Common DDBA 8531 Week 2 mistakes, and how to avoid them
Collect documents before drawing anything. Committee minutes, charters, policies and job postings often reveal who must approve a purchase. Interview one or two participants if you can, and ask who else they had to convince. Remember that one person may hold several roles. When stating tests, use the participant's language: an engineer asks about service response, not value. Look for the person nobody planned for, such as someone who controls access to data or facilities. A small diagram of who spoke to whom can reveal brokers. Acknowledge what your sources miss, such as hallway conversations. Finally, translate the map into advice: whom should a seller meet, and when, given what the map shows?
Get a DDBA 8531 Week 2 example written to your instructions
Pick the purchase, even roughly described, and send it with the Week 2 prompt and rubric. A role table with an evidence column, the commentary and a small influence diagram are drafted inside 24 to 48 hours, at no cost the first time. Placements the sample cannot support from sources are labeled as inferences, not asserted.
More DDBA 8531 papers and DBA samples
- DDBA 8531 Week 1: Buying Role Discussion
- DDBA 8531 Week 3: Derived Demand Trace
- DDBA 8531 Week 4: Tender Analysis
- DDBA 8531 Week 5: Switching Cost Brief
- DDBA 8531 Week 6: Pitch Peer Critique
- DDBA 8531 Week 7: Customer Value Case
- DDBA 8531 Week 8: Buyer Risk Memo
- DDBA 8531 Week 9: Relationship Literature Appraisal
- DDBA 8531 Week 10: Stage-by-Stage Account Plan
- DDBA 8531 Week 11: Veto Holder Seminar Paper
- DDBA 8524 Week 2: Authority Analysis
- DDBA 8522 Week 2: Sustainability Definition Paper
- DDBA 8521 Week 2: Rejected Change Diagnostic
- DDBA 8511 Week 2: Idea Origin Case Analysis
DDBA 8531 Week 2 questions, answered
Where can I find a free DDBA 8531 Week 2 sample paper?
Scroll to the paper section for the complete infusion pump map: seven rows, a minutes chart and commentary, all free.
What purchase does the DDBA 8531 Week 2 map cover?
A three-hospital health system's replacement of about 1,350 infusion pump channels for about $4.2 million.
Who was the overlooked gatekeeper?
A pharmacy administrator who controlled vendor access to the drug library that configures each pump.
Which participant held a formal veto by charter?
The clinical informatics lead, who must approve any device that connects to the network.
Where did the evidence come from?
Committee minutes, the committee charter, the vendor access policy, a job posting and two interviews.